Loss-of-Function Mutations in APOC3 and Risk of Ischemic Vascular Disease

Loss-of-function mutations in APOC3 were associated with low levels of triglycerides and a reduced risk of ischemic cardiovascular disease. (Funded by the European Union and others.).